Members of House and Senate ask for documents behind FDA change in FDA protocol

If you click here, you can read the entire letter sent by Rep. Chris Smith (R-NJ) and Senator James Lankford (R-OK), joined by 73 of their colleagues, to Dr. Robert M. Califf, M.D., the FDA’s Commissioner, “requesting information about the agency’s recent decision to change its policies regarding the abortion drug mifepristone.”

The letter is respectful and courteous, but asks for data that was not forthcoming last month when the FDA relaxed safety standards and modified the protocol for mifepristone/misoprostol chemical abortions that had been in place since September of 2000.

This was a great coup for the Abortion Industry, particularly Planned Parenthood. The FDA was retroactively giving its seal of approval to various important changes the Abortion Industry made unilaterally.

Click here for more from National Right to Life.